PT Medikaloka Hermina Tbk

Total Valuation

PT Medikaloka Hermina Tbk carries a market capitalization of 13.56T, placing it among publicly traded companies globally. Its enterprise value stands at 25.48T, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

PT Medikaloka Hermina Tbk currently has 15.37B shares outstanding.

Valuation Ratios

PT Medikaloka Hermina Tbk trades at a trailing price-to-earnings ratio of 52.06. The price-to-sales ratio is 3.21, and the price-to-book ratio stands at 6.73.

Enterprise Valuation

On an enterprise value basis, PT Medikaloka Hermina Tbk trades at an EV/EBITDA multiple of 28.17 and an EV/FCF ratio of 11.77. The EV/Sales ratio of 3.76 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 28.17 provides insight into valuation relative to core operating earnings.

Financial Position

PT Medikaloka Hermina Tbk maintains a current ratio of 1.76, meaning it holds 1.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 51.47, indicating elevated leverage, while an interest coverage ratio of 3.97 demonstrates adequate ability to service its debt obligations.

Financial Efficiency

PT Medikaloka Hermina Tbk posts a return on equity of 13.55 and a return on invested capital of 6.92.

Taxes

Over the trailing twelve months, PT Medikaloka Hermina Tbk has paid 185.87B in income taxes, reflecting an effective tax rate of 25.91.

Stock Price Statistics

PT Medikaloka Hermina Tbk's stock has declined approximately -39.59044% over the past 52 weeks. The 50-day moving average sits at 956.80, while the 200-day moving average is 1,289.78.

Income Statement

Over the trailing twelve months, PT Medikaloka Hermina Tbk generated 6.78T in revenue and converted that into 417.63B in net income, yielding earnings per share of 34.59. EBITDA reached 904.35B, while operating income came in at 904.35B.

Balance Sheet

PT Medikaloka Hermina Tbk holds 1.42T in cash and equivalents against 3.61T in total debt, resulting in a net debt position of 2.18T. Total book value stands at 3.23T, with working capital of 1.25T providing operational flexibility.

Cash Flow

After subtracting -2.00T in capital expenditures, free cash flow totaled -2.00T - equivalent to -129.87 per share.

Margins

PT Medikaloka Hermina Tbk operates with a gross margin of 34.35, reflecting its pricing power and cost economics. The operating margin of 13.34 and net profit margin of 6.16 provide insight into operational efficiency.

Dividends & Yields

Stock Splits

PT Medikaloka Hermina Tbk's most recent stock split took place on July 30, 2021 with a 1:5 split ratio.

Scores

PT Medikaloka Hermina Tbk posts an Altman Z-Score of 3.95, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.